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Abstract: Chronic wounds are a substantial clinical problem affecting millions of people 
worldwide. Pathophysiologically, chronic wounds are stuck in the inflammatory state of heal-
ing. The role of bacterial biofilms in suppression and perturbation of host response could be an 
explanation for this observation. An inhibiting effect of bacterial biofilms on wound healing 
is gaining significant clinical attention over the last few years. There is still a paucity of suit-
able animal models to recapitulate human chronic wounds. The etiology of the wound (venous 
insufficiency, ischemia, diabetes, pressure) has to be taken into consideration as underlying 
pathophysiological mechanisms and comorbidities display tremendous variation in humans. 
Confounders such as infection, smoking, chronological age, sex, medication, metabolic dis-
turbances, and renal impairment add to the difficulty in gaining systematic and comparable 
studies on nonhealing wounds. Relevant hypotheses based on clinical or in vitro observations 
can be tested in representative animal models, which provide crucial tools to uncover the patho-
physiology of cutaneous skin repair in infectious environments. Disposing factors, species of 
the infectious agent(s), and time of establishment of the infection are well defined in suitable 
animal models. In addition, several endpoints can be involved for evaluation. Animals do not 
display chronic wounds in the way that humans do. However, in many cases, animal models 
can mirror the pathological conditions observed in humans, although discrepancies between 
human and animal wound repair are obvious. The use of animal models should be refined and 
replaced whenever possible, and reproducibility and clinical relevance should be strived. This 
review aimed at giving an overview of the model systems and major findings for inspiration for 
clinicians and researchers involved in handling chronic nonhealing wounds. Relevant animal 
models on wound repair are discussed, and our novel wound model on the host/pathogen inter-
play is presented. In this model, murine wounds are stuck in a polymorphonuclear neutrophil 
granulocyte-dominated inflammation due to the presence of visually confirmed Pseudomonas 
aeruginosa biofilm located in the dermis and subcutaneous fatty tissue. 
Keywords: pathogen interplay, chronic wound science, Pseudomonas aeruginosa biofilm 
Introduction
The incidence of chronic wounds and its associated complications are growing epi-
demically, and the management of infections, for example in diabetic foot ulcers, is 
crucial for the patients.1 To date, no known animal model is representative of clinically 
important comorbidities preceding the formation of a chronic wound. 
Pathology of human chronic wounds is a challenge to researchers. In clinical 
studies, strict inclusion criteria ensure group homogeneity to a certain extent, but 
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conclusions are not easily drawn from studies of these often 
multimorbid patients. In patients suffering from venous 
insufficiency, accumulation of fibrinous exudates in the lower 
extremities may form substantial edema. With time, stasis 
dermatitis and lipodermatosclerosis will develop followed by 
minor defects in the skin barrier, ultimately causing venous 
leg ulcers that are difficult to reproduce in animal models 
due to the complexity of human pathophysiology. However, 
animal models with venous hypertension that cause altered 
flow and inflammation are described.2 It is believed that 
diabetic wounds develop due to a reduced healing process 
as a consequence of impaired cellular functions.1 Diabetic 
wound healing models are well described by Watters et al 
who have developed a wound model on type 1 diabetic mice.3 
In this model, biofilm-like aggregates of bacteria in wound 
sections are visualized. The need for type 2 diabetic models 
is perhaps even more urgent. Pressure wounds can arise rela-
tively rapidly during continued pressure. In one integrated 
clinical study, in vivo and in vitro studies were reviewed 
revealing that pressure ulcers develop in 1 to 4–6 hours.4 
A porcine model on pressure wounds is suggested by Hyodo 
et al who applied a constant pressure over denervated skin.5 
Atherosclerotic disease in extremities is a prerequisite for 
the development of painful ischemic chronic wounds. Skin 
flap models reproduce this ischemia.6 
Despite these clinically relevant models that reflect parts 
of wound chronicity, there is still an urgent need for animal 
models that reproduce the inflammatory state that character-
izes chronic wounds. An explanation for hyperinflammation 
could be the presence of bacterial biofilms residing deeply 
in the wound bed, perturbing normal tissue regeneration. 
Choice of animal species
While choosing a certain species for an animal wound heal-
ing model, the comparability of animal skin anatomy to 
human skin should be taken into consideration. In animal 
models, a standardized structural damage is inflicted to 
the skin, whereas in humans, several factors, even some 
unknown factors, add to the appearance of a recalcitrant 
wound. Furthermore, human chronic wounds are most often 
full-thickness wounds, but some animal models utilize only 
partial-thickness wounding.7 
A successful animal model on wound repair enables 
researchers to identify certain mechanisms or key molecules 
in skin regeneration. A clinically relevant animal model 
should display impact on wound healing capacity post-
challenge. However, a gap exists between the current science 
on animal wound healing and the development of new clinical 
treatment modalities. Animal models reflecting chronicity 
of wounds may only have distinct strengths characterizing 
different aspects of nonhealing wounds as the reproducibility 
of more confounding factors are almost impossible to obtain 
in one animal model. Choice of model system is therefore 
highly dependent on the hypothesis which has to be tested. 
Moreover, an already established model may be subject to 
ongoing adjustments in order to enable careful testing of the 
generated hypotheses.
The most widely used animals for wound healing models 
are rodents and larger mammals. 
Rodents
Immune response to infection between species can only be 
a reflection of clinical matter. Qualitative differences in host 
response to wounding are a challenge in the use of rodents.8 
Small rodents such as mice are extensively used as models for 
skin repair, many offering several advantages. Rat and rabbit 
physiology is closer to that of humans, but fewer immuno-
logical evaluation tools of host response are available. The 
hairless guinea pig model is closer to human skin anatomy,9 
which also meets the limitations regarding comparability in 
host response.
Due to low cost, easy handling, and the fact that rodents 
are readily obtainable, it enables researchers to include a 
relatively large number of animals. Intervariability in host 
response even in inbred strains of mice is inevitable, but 
is nevertheless reduced as compared to outbred strains. 
In addition, a substantial number of knockout mouse 
strains and a vast selection of immunological tools for the 
evaluation of host response are available for murine models. 
Genetically modified mice are helpful in the elucidation 
of the hyperinflammatory state of nonhealing.8 However, 
using small rodents to reflect human wound closure has 
limitations. For example, human skin has a thicker epi-
dermis10 and a more dense appendage density due to hair 
follicles11 than murine skin. Importantly, murine healing 
is dominated by myofibroblast- mediated contraction due 
to the presence of striated panniculus carnosus, which 
causes healing by primary intention and not secondary 
intention, which is observed in humans.12 One method to 
overcome wound contraction is by the use of a rabbit ear 
model13,14 in which the underlying cartilage functions as a 
splint, thereby minimizing wound contraction. This model 
is commonly used for the study of topical growth factors 
and for the assessment of Pseudomonas aeruginosa (PA) 
biofilm in wounds.15,16 Another way of bypassing wound 
contraction is by the actual splinting of murine wounds, for 
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example, described in Schierle et al17 and Galiano et al14 in 
which wounds heal by the formation of granulation tissue. 
In these studies, the questionable translatability of acutely 
inflicted wound to clinically chronic wounds should be 
addressed and the presence of local wound biofilm should 
however be visualized. 
Larger mammals
Larger animals such as dogs, pigs,18,19 and even primates 
have more human-like physiology of the skin in certain 
areas; however, these animals are significantly more expen-
sive, not to mention the logistic challenges in the housing 
of these larger mammals. Fewer tools are available for host 
response evaluations as compared to rodent tools. In order to 
choose larger mammal animal models, researchers therefore 
have to justify the higher costs and fewer possibilities of the 
evaluation, and this may be the explanation for the sparse 
literature on for example, porcine wound healing despite 
the greater comparability to human skin.18 An advantage in 
porcine wound healing models is that the skin is devoid of 
fur but coarse singular hairs and besides their skin is firmly 
attached to the underlying structures like in humans.10 How-
ever, porcine skin is less vascular than human skin, and it 
has apocrine, not eccrine, sweat glands.20 Summerfield et al 
have described the similarities between porcine and human 
immune cells.21 Taken together, the impact of these findings 
on wound healing is not known.18
Induction of wounds
Almost all animal models of chronic wounds are established 
by the induction of a structural damage of the skin barrier, 
each model yielding its own defined depth and area. There 
are numerous methods for generating the skin defect; they 
include acute surgical wounds,22,23 abrasions, punch wounds, 
extrinsic pressure,24 scalding, or burn wounds.25 Acute 
wounds subjected to a single clinical relevant circumstance 
such as ischemia or diabetes are therefore the cornerstone 
in animal models of wound chronicity.26 
Establishment of a chronic wound 
environment
Human skin is constitutively an excellent effective barrier, 
protecting us from numerous microbial exposures every day. 
Structural damage of the skin barrier, no matter the nature 
of the underlying pathology, provides the possibility for 
microbes to colonize deeper layers of the human skin.27 If the 
fundamental disposing factor is not corrected, the coloniza-
tion will proceed to the establishment of a permanent state 
of biofilm infection ultimately perturbing and impairing the 
host response.28–30 
Microbes gaining access to exposed subcutaneous fatty 
tissue will be able to cause local infection as the mature 
biofilm is resistant to host response and antimicrobial 
therapy.29 Human comorbidity such as systemic disease with 
chronically elevated inflammatory markers, malnutrition, 
fluctuating glucose levels, or neuropathies is a conducive 
microenvironment for a biofilm establishment.
In a moist hypoxic and nutritious environment, bacte-
ria will thrive and the net result is a prolonged or chronic 
inflammatory state delaying or outright impairing wound 
healing.27,28 
Biofilm inhibits innate host response29,31 and remains 
refractory to relevant antibiotics. Cascades of collateral 
damage locally in the tissue decreases the possibility for 
the wound to heal.32 The actual mechanisms causing the 
pathology around biofilms are not completely understood, 
but there is a linkage to protease activity and immunosup-
pression.31,33 A suitable animal model should display this 
prolonged inflammatory state, characterized by constant 
release of cytokines causing local tissue inflammation. 
Furthermore, biofilm-like structures should be able to be 
visualized deeply in the wound bed.
Bacterial biofilms in chronic wound 
science
Cutaneous wound healing is a well-orchestrated and dynamic 
process (Figure 1) that runs through three phases: inflamma-
tion, tissue proliferation, and tissue remodeling.34 Human 
chronic wounds are characterized by senescent fibroblasts, 
a hyperproliferative and thickened epidermis, and prolonged 
release of proinflammatory cytokines, arresting the wound 
bed in a chronic inflammatory state. A reason for this arrest 
is essential in the understanding of recalcitrance of wounds. 
The role of bacterial biofilms in chronicity of wounds is 
only recently appreciated.7 James et al found biofilms in 30 
of 50 chronic wounds, but only in one in 16 acute wounds,32 
which is in accordance with the general belief that approxi-
mately half of all chronic wounds contain biofilm.35 Common 
bacteria found in chronic wounds are Staphylococcus aureus 
(SA), Enterococcus species, PA, Proteus species, and anero-
bic bacteria36,37 with some discrepancies observed between 
wounds of different etiology.38 An infectious burden of >105 
microbes/g tissue is traditionally considered as infection;39 
however, classical clinical signs of acute inflammation (calor, 
dolor, rubor, and tumor) are not always present in diabetic 
patients40 or in chronic low-grade biofilm infections.41 A clear 
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distinction between bacterial colonization and clinical infec-
tion would be of tremendous value.42 
The microbiology of chronic wounds of different origins 
has been somewhat of a black box for many years for several 
reasons. The sampling of wounds with no classical signs of 
infection is neglected, and furthermore, Gram-negative rods 
are often not identified as specimen and no susceptibility 
pattern is retrieved as this flora is considered nonpathogenic 
resident bacteria of the chronic wound.28 However, PA grow-
ing in biofilms is now appreciated as a key role player in 
arresting wounds in the inflammatory state of healing.35,43 An 
uneven distribution of microorganisms has been described. 
PA biofilms are located in the subcutaneous fatty tissues of 
the wounds44 (Figure 2). Comparing different species, PA 
tends to be located deeper in the wound bed than SA,44,45 and 
in tissue biopsies from chronic wounds, the former appeared 
more virulent than the latter, evaluated by the number of neu-
trophils accumulating at the site.46 Thus sampling technique 
is of utmost importance – especially, biopsies from surgical 
revision have proven to be superior in revealing the actual 
microbiology of the wounds as compared to conventional 
swabbing.35,43
Inflammation Proliferation
Maturation
Tissue remodeling
Neutrophil infiltration –
respiratory burst
Macropage accumulation
Release of growth factors
Angiogenesis
Deposition of collagen
Formation of granulation tissue
Release of growth factors
Phagocytosis
Figure 1 Normal wound healing is characterized by three dynamic and timely overlapping phases: inflammation, proliferation, and maturation.
Note: The chronic wounds are believed to be stuck in the inflammatory phase of wound healing, which in a healing environment will last for only 1–2 days. 
Figure 2 A diagram of human skin anatomy and contents of the anatomical layers.
Note: Note the subcutaneous localization of Pseudomonas aeruginosa biofilm.
Human
skin
• Epidermis
• Dermis
• Subcutaneous fatty tissue
Avascular squamous epithelium of
keratinocytes
Collagen, elastic fibers, blood vessels,
adnexa of skin
Pseudomonas aeruginosa biofilm,
loose connective tissue, fat
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In one study, PA was significantly more often identified 
in wound material as compared to swabs.35 Another clinical 
relevance of PA is that infection by this microbe reduces the 
success rate in split-thickness grafting of chronic venous 
leg ulcers.47 It may also contribute to the large area of leg 
ulcers.36 Wound biopsies or other wound tissue can be 
examined by light microscopy after Gram-staining or by 
fluorescence microscopy after staining with fluorescent in 
situ hybridization (FISH) techniques – especially the use of 
peptide nucleotide acid (PNA) probes has proven useful in 
revealing biofilms residing within the nonhealing wounds.35
Animal models of chronic wounds caused by biofilms 
are emerging, but this research area is still not thoroughly 
investigated. The idea is that the biofilm in itself creates a 
chronic infection, and one of the biggest challenges in the 
creation of a representative animal model is to somehow 
mimic this low-grade inflammation. Due to the described 
observations, the recent animal models have focused on 
embedding bacteria inside biofilms or induce biofilm growth 
and organization before establishing the wound infection in 
the animals.48 Examples of relevant animal models on chronic 
wounds are summarized in Table 1. 
In a dermal punch wound model on rabbit ears, SA 
biofilm creates a low-grade and persistent host response, 
impairing epithelialization and granulation tissue forma-
tion.16 Zhao et al developed a reproducible full-thickness 
diabetic punch wound model on mice challenged by in vitro 
produced PA biofilm.49 They reported a PA biofilm-induced 
impairment of wound healing. In this model, bacteria in 
biofilms are located in the scab of wounds, which is not 
the case in humans.49,50 In another full-thickness excisional 
wound murine model, Dalton et al demonstrated impaired 
wound healing in a polymicrobial biofilm infection model 
in comparison with single species infection, suggesting 
a significant contribution of interspecies interactions on 
delayed healing.48 Interestingly, an antimicrobial dressing 
was found counteracting the detrimental PA biofilm effects 
on wound healing underlining the usefulness of such models 
to perform preclinical testing of potential beneficial treat-
ment strategies.51
Recalcitrance to antibiotics of biofilms52–55 can to a high 
degree explain why antibiotics are not convincingly effec-
tive in handling nonhealing wounds. Necessary antibiofilm 
strategies of high doses and combination therapy combined 
with suitable debridement are suggested.
Endpoints for wound healing 
assessment
Clinically relevant endpoints as a parameter for the general 
condition of the animal are daily weighing and temperature 
assessment. Various clinical scoring systems are avail-
able – besides giving the opportunity to obtain repeated 
measurements on the same animal; this is actually a 
mandatory evaluation of the status of any animal used for 
experiments.56 
In human studies, the primary end point is the appear-
ance of granulation tissue, the reduction of wound area or 
ultimately reepithelialization. In case of evaluation of effi-
cacy of a given treatment, the type of sample and technique 
used to obtain the material are of substantial significance. 
Biofilms cannot be identified and reported from a swab due 
to the superficial nature of the sample.35 Another issue is 
that the microbiological examinations are not performed 
uniformly or standardized, and often not everything cultured 
is identified or even reported as clinicians often only retrieve 
the material when the wound appears clinically infected 
with the classical signs of inflammation. With the develop-
ment of newer molecular techniques, genetic material from 
numerous different pathogens can be detected in wound 
biopsies or discarded material from revisions.57 So-called 
microbiomes of the wounds can vary over time.58 However, 
the actual clinical significance of these findings by the next 
generation molecular techniques still needs to be solved. 
Interestingly, a recent case study demonstrated the dynamics 
of bacterial constituents during the course of wound healing. 
Initially Enterobacteriaceae and SA dominate the flora, 
Table 1 Some examples of animal models on chronic wounds
Animal species Wound etiology Microbe Duration of experiment Authors
Cyclophosphamide-treated mice Cut wound 3.7×106 Staphylococcus aureus 60 hours Akiyama et al22
Pigs Partial thickness by the use of 
electrokeratome
107 CFU/mL
Staphylococcus aureus
48 hours Davis et al70
Mice Full-thickness punch wound Staphylococcus aureus
Staphylococcus epidermidis
9 days Schierle et al17
Diabetic mice Full-thickness excision wound 104 Pseudomonas aeruginosa 16 days Watters et al62
Diabetic mice Full-thickness punch wound Pseudomonas aeruginosa 28 days Zhao et al49
Rabbits Full-thickness punch wound 106 Staphylococcus aureus 12 days Gurjala et al16
Cyclophosphamide-treated mice Full-thickness punch wound 5×104 Acinetobacter baumanii 23 days Thompson et al71
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and their disappearance during antibiotic treatment seems 
to initiate wound healing even though the bacterial load 
remains stationary. Thus, the control of certain pathogens 
seems to favor a healing process while the presence of other 
microorganisms is indifferent.59
Wound closure is perhaps the most important clinical 
parameter in following patients with nonhealing wounds.60 
Laboratory animals can be followed in the same manner by 
digital planimetry, for example, in the assessment of murine 
skin contraction.61 Photos of the wounds are retrieved in a 
standardized manner (distance from wound and precisely over 
the middle of the wound) and are subsequently transferred 
to a computer-based program for estimating the sizes of the 
wounds throughout the assessment period. These can then be 
compared with the initial sizes of the affected areas, express-
ing healing as percentage of wound closure by the equation 
(A
0
–A
t
)/A
0
×100,60,62 in which A
0 
 is the area of the wound at 
the beginning of the experiment, and A
t 
is the present wound 
area. Such clinical assessment with repeated measurements 
on the same animals has the potential to provide strong sta-
tistical analysis with paired parameters since each animal 
functions as its own control. 
In vivo imaging systems using fluorescent or biolumi-
niscent microorganisms can be useful for the assessment of 
wound infections in animal models. They provide repeated 
measurements on the same animals, following the course 
of the infections, thus reducing the number of experimental 
animals required. The superficial localization of infection in 
the wound enables exciting new perspectives by means of in 
vivo imaging systems in chronic wound science.63
An example of a chronic PA biofilm 
infection model 
Biofilms induce a persistent cellular inflammatory response 
evaluated by the accumulation of polymorphonuclear 
neutrophil (PMN) granulocytes and elevated levels of 
interleukin-1β.64 Our chronic wound model is a modification 
of our murine burn wound model.65 A thermal lesion provides 
the structural damage, a full-thickness necrosis, necessary for 
the establishment of a chronic biofilm infection.66 This model 
provides the possibility to study the impact of PA biofilms on 
wounded skin in vivo. A third-degree burn to anesthetized 
mice was induced, the burn taking up 6% of the total body 
surface area (Figure 3). To circumvent systemic immuno-
suppression caused by the burn, PA biofilm was injected 
4 days after wound infliction. In order to mimic the spatial 
distribution of bacteria observed clinically, the  challenge 
solution is injected deep in the wound bed to reach the dermis 
and the subcutaneous fatty layer (Figure 2). If planktonic 
PA is injected subcutaneously beneath the affected skin of 
mice, systemic dissemination and spreading to the organs 
yielding severe sepsis 2 days post challenge is observed.66 
However, if the bacteria are embedded in seaweed alginate to 
mimic biofilm organization, no systemic spread of bacteria 
is observed and the mice continue to be locally infected for 
a minimum of 14 days.65
Using specific PA staining with PNA-FISH on in toto 
removed wounds from these mice, biofilm-like structures 
in both dermis and subcutaneous layers of the skin were 
revealed.65 Inflammatory cells were accumulated in close 
proximity to the biofilms. As for quantitative bacteriology, a 
significantly larger amount of bacteria detected by counting 
of CFU/wound in BALB/c mice as compared to C3H/HeN 
was found at day 5. When looking at the course of infection, 
BALB/c mice had significantly more bacteria at day 5 than 
day 2, and a significant reduction again at day 7 as opposed 
to C3H/HeN. In this inbred mouse strain, quantitative bac-
teriology was stable throughout the study.
A significant observation was the arrested inflamma-
tion in a state dominated by PMNs in mice with established 
biofilm infection using this model. This was in contrast to 
the normal shift of inflammation to a cellular response with 
mononuclear cells observed in mice challenged with alginate 
beads without PA. Furthermore, levels of interleukin-1β are 
elevated locally in the biofilm-infected wounds, especially 
in the relatively susceptible BALB/c-strain of mice, which 
are immunologically characterized by a Th2-dominating 
response.65 This strain did not reach infection control during 
the experiment as opposed to CH3/HeN mice.65 Interestingly, 
chemoattractant for PMNs, keratinocyte-derived chemokine, 
was significantly higher at both day 2 postinfection and day 
5 in serum from PA-infected BALB/c mice but only day 2 
postinfection for the C3H/HeN strain.
This novel animal model mimics human nonhealing 
wounds, arrested in a hyperinflammatory state evaluated by 
PMN infiltration and interleukin-1β. The arrest is caused by 
the presence of biofilm-like structures situated deeply in the 
murine wound beds.  
Quantitative bacteriology analysis on homogenized 
total excised wounds was always included as an endpoint, 
excluding animals with wounds colonized with additional 
microorganisms acquired after the initiation of the experi-
ments. In addition, microscopy of excised wounds by use of 
PNA-FISH techniques is occasionally included to show the 
presence of biofilms within the wounds.65
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Figure 3 The procedure. 
Notes: (A) The hot air blower, (B) the template with window, (C) the sledge, (D) injection of hypnorm dormicum SC, (E) shaving the mouse, (F) placing the mouse on the 
sledge, (G) covering the mouse with fire blanket, (H) placing the template on the mouse, (I) the arrangement, (J) measurement of the temperature, (K) 330ºC, (L) initiating 
the induction of the thermal injury, (M) keeping the mouse for 7 s into the hot air, (N) clinical manifestation of the thermal injury, (O) injection of 1 ml of NaCl, (P) the 
mice 4–5 h after induction of the thermal injury. Reproduced from Pseudomonas Methods and Protocols, volume 1149 of the series Methods in Molecular Biology. ‘Burn Mouse 
Models’, pp 793–802, 29 March 2014. Calum H, Høiby N, Moser C. With permission of Springer.72
Abbreviation: SC, subcutaneously.
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Patients suffering from chronic wounds often display 
comorbidity and therefore have significant increase in sys-
temic inflammatory markers such as leucocytes, C-reactive 
protein or procalcitonine, or sign of systemic infections. In 
our model, flow cytometry analysis on whole blood shows 
significant differences on leucocytes between chronically 
infected mice and mice without chronic wounds, indicating 
a systemic impact of the wound infliction.65 
Numerous inflammatory markers can be revealed locally 
in the wounds compared with controls in wound exudates 
collected in a standardized manner67 or wound tissue. Unfor-
tunately, no marker has been proven to be a characteristic 
of nonhealing wounds probably due to the heterogeneity of 
wound pathology. Animal models have a substantial advan-
tage as the wound removed in toto can be examined after 
homogenization and the supernatants can be subsequently 
analyzed by enzyme-linked immunosorbent assay (ELISA), 
or multiplex fluorescent Luminex immunoassay, or quantita-
tive polymerase chain reaction techniques.65 
Inflammatory characterization and degree are evaluated 
histopathologically on excised whole chronic wounds after 
staining with hematoxylin and eosin.65 In a time course of 
14 days post wound infliction, BALB/c mice display a larger 
number of PMNs peripherally in the wounds than centrally 
(authors’ observations, 2014). Moreover, an arrestment in the 
proinflammatory stage dominated by PMNs was observed.65
This model is an easily obtainable and reproducible 
method to study the impact of biofilm infection on host 
response. Furthermore, it can be used for novel experimental 
treatments such as growth factors in combination with antibi-
otics or other antibiofilm interventions such as quorum sens-
ing inhibitors, azithromycin, and acetic acid.68,69 As a model 
for wound healing, assessment of wound closure is a possibil-
ity (Figure 4). Figure 4 unpublished study was approved by 
the Animal Ethics Committee of Denmark (2010/561-1766). 
The authors confirm that all experiments were performed fol-
lowing National and European Union guidelines.
Conclusion 
There is an urgent need for the focus on the host response–
biofilm interaction in wound science, but how to create an in 
vivo model that recapitulates the complexity of human wound 
chronicity in an acceptable manner still remains unanswered. 
Although they are merely approximations of clinical condi-
tions due to phenotypic differences in skin anatomy and host 
response profile between species, animal models provide an 
indispensable insight into skin repair. 
Current refined models serve as a crucial basis for testing 
hypotheses observed clinically and in vitro. The ultimate goal 
using animal models is to identify the key role-players in recal-
citrant wound healing. This could be used in the evaluation of 
treatment options that are clinically beneficial for the growing 
population of patients suffering from chronic wounds.
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